Use of the ketogenic diet as a strategy for the management of patients with refractory epilepsy: A literature review
DOI:
https://doi.org/10.37497/ijhmreview.v5i1.150Keywords:
Refractory epilepsy, Ketogenic diet, Quality of life.Abstract
Introduction: Epilepsy is a disease that affects millions of people in all parts of the world. Epileptic seizures occur in patients in a partial or generalized way, depending on the degree of disease activity. Currently, there are many drugs available in the market, which have several mechanisms of action and can be used alone or concomitantly. However, in some patients, especially in children and adolescents, these drugs are ineffective and incapable of promoting the control of both the frequency and severity of epileptic seizures, which are called refractory epilepsy. Thus, the search for alternative treatments capable of controlling the frequency and intensity of refractory epileptic seizures is incessant and intense, and among the strategies currently used, the ketogenic diet (DC), which consists of a high lipid intake and low carbohydrate and protein intake and has provided an improvement in patients' quality of life, mainly in children and adolescents with refractory epilepsy. Objective: To review the literature on the benefits of CD, as an adjuvant and alternative treatment, in the treatment of refractory epilepsy, mainly in children and adolescents. Methodology: The study was carried out through a bibliographical and integrative review of the literature, through the compilation of scientific articles and books on the proposed theme. The information was searched in the Google academic database, Scielo and PubMed. The keywords used to search the scientific articles were: Epilepsy, Refractory Epilepsy, Ketogenic Diet. For the preparation of this study, publications were searched from 2008 to 2018, taking into account the relevance and relevance of the theme, whose title established the relationship with the study. Of the publications found, 22 were used. Conclusion: It is concluded that CHD presents itself as an important therapeutic option that is very safe, cheap and effective and, therefore, can be used in the management of patients with refractory epilepsy, mainly in children and adolescents.Downloads
Published
How to Cite
Issue
Section
License
Authors who publish in this journal agree to the following terms: The author(s) authorize the publication of the text in the journal; The author(s) guarantee that the contribution is original and unpublished and is not in the process of being evaluated by any other journal(s); The journal is not responsible for the opinions, ideas, and concepts contained in the texts, as these are the sole responsibility of their respective author(s); The editors reserve the right to make adjustments to the text in order to ensure that it adheres to the standards of the journal. Authors retain the copyrights and grant the journal the right of first publication, with the article simultaneously licensed under the Creative Commons Attribution License which allows the sharing of the article with the acknowledgment of authorship and initial publication in this journal. Authors are authorized to take additional contracts separately, for the non-exclusive distribution of the version of the article published in this journal (e.g. publication in an institutional repository or as a book chapter), with the acknowledgment of authorship and initial publication in this journal.
Authors are allowed and encouraged to publish and distribute their work online (e.g. in institutional repositories or on their personal webpage) at any point before or during the editorial process, as this can generate productive changes as well as increase the impact and citation of published work (See The Effect of Free Access at http://opcit.eprints.org/oacitation-biblio.html)